X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17610) 17610
Newsletter (618) 618
Newspaper Article (503) 503
Book Chapter (236) 236
Magazine Article (115) 115
Book / eBook (30) 30
Dissertation (9) 9
Publication (8) 8
Transcript (6) 6
Book Review (4) 4
Trade Publication Article (4) 4
Web Resource (4) 4
Conference Proceeding (3) 3
Government Document (2) 2
Reference (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13772) 13772
female (7367) 7367
male (6767) 6767
pulmonary embolism (6164) 6164
middle aged (5579) 5579
aged (4962) 4962
pulmonary embolism - prevention & control (4879) 4879
risk factors (4578) 4578
adult (4355) 4355
thromboembolism (3937) 3937
pulmonary-embolism (3760) 3760
prevention (3718) 3718
venous thromboembolism (3649) 3649
anticoagulants - therapeutic use (3065) 3065
deep-vein thrombosis (3031) 3031
surgery (2999) 2999
thrombosis (2692) 2692
pulmonary embolism - etiology (2400) 2400
peripheral vascular disease (2143) 2143
treatment outcome (2060) 2060
anticoagulants (2026) 2026
hematology (1975) 1975
aged, 80 and over (1974) 1974
retrospective studies (1903) 1903
mortality (1872) 1872
venous thrombosis - prevention & control (1791) 1791
medicine, general & internal (1785) 1785
risk (1701) 1701
postoperative complications - prevention & control (1670) 1670
cardiac & cardiovascular systems (1639) 1639
venous thrombosis (1617) 1617
research (1600) 1600
care and treatment (1579) 1579
molecular-weight heparin (1545) 1545
prophylaxis (1537) 1537
diagnosis (1463) 1463
deep vein thrombosis (1433) 1433
venous thromboembolism - prevention & control (1419) 1419
medicine & public health (1359) 1359
incidence (1352) 1352
abridged index medicus (1295) 1295
respiratory system (1288) 1288
health aspects (1273) 1273
heparin - therapeutic use (1270) 1270
time factors (1249) 1249
prospective studies (1240) 1240
pulmonary embolism - diagnosis (1204) 1204
risk-factors (1194) 1194
venous thrombosis - etiology (1191) 1191
adolescent (1157) 1157
risk assessment (1157) 1157
anticoagulants - administration & dosage (1150) 1150
analysis (1140) 1140
pulmonary embolism - epidemiology (1134) 1134
pulmonary embolism - drug therapy (1093) 1093
patients (1089) 1089
thromboembolism - prevention & control (1061) 1061
management (1019) 1019
heparin (1011) 1011
deep venous thrombosis (1006) 1006
vena cava filters (988) 988
cancer (979) 979
recurrence (975) 975
embolisms (972) 972
complications (957) 957
medical research (954) 954
health risk assessment (942) 942
follow-up studies (941) 941
heparin, low-molecular-weight - therapeutic use (938) 938
anticoagulants - adverse effects (924) 924
venous thromboembolism - etiology (909) 909
drug therapy (904) 904
pulmonary arteries (883) 883
thrombophlebitis - prevention & control (869) 869
medicine, experimental (859) 859
warfarin (854) 854
thromboprophylaxis (840) 840
venous thrombosis - epidemiology (817) 817
animals (809) 809
orthopedics (808) 808
pregnancy (808) 808
venous thromboembolism - epidemiology (805) 805
prognosis (796) 796
young adult (772) 772
embolism (766) 766
therapy (748) 748
cardiology (729) 729
fibrinolytic agents - therapeutic use (716) 716
pulmonary embolism - mortality (715) 715
venous thrombosis - drug therapy (684) 684
stroke (683) 683
internal medicine (679) 679
hemorrhage - chemically induced (669) 669
enoxaparin (662) 662
prevalence (653) 653
anticoagulation (652) 652
hospitals (650) 650
pulmonary embolism - diagnostic imaging (647) 647
heparin - administration & dosage (640) 640
chronic obstructive pulmonary disease (637) 637
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17490) 17490
German (628) 628
French (436) 436
Japanese (183) 183
Russian (182) 182
Spanish (146) 146
Italian (131) 131
Portuguese (55) 55
Czech (54) 54
Polish (49) 49
Chinese (42) 42
Turkish (21) 21
Danish (18) 18
Hungarian (18) 18
Dutch (17) 17
Swedish (15) 15
Norwegian (14) 14
Finnish (12) 12
Croatian (10) 10
Ukrainian (10) 10
Romanian (8) 8
Serbian (7) 7
Hebrew (6) 6
Korean (6) 6
Bulgarian (5) 5
Slovak (3) 3
Bosnian (2) 2
Slovenian (2) 2
Arabic (1) 1
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 0009-7322, 07/2005, Volume 112, Issue 3, pp. 416 - 422
In a randomized trial in patients with proximal deep-vein thrombosis, permanent vena cava filters reduced the incidence of pulmonary embolism but increased that of deep-vein thrombosis at 2 years... 
Prevention | Pulmonary embolism | Vena cava filters | Trials | Thrombosis | Recurrence | Pulmonary Embolism - prevention & control | Follow-Up Studies | Venous Thrombosis - therapy | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Vena Cava Filters | Pulmonary Embolism - mortality | Vitamin K - antagonists & inhibitors | Female | Aged
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
...) recommendations based on high-quality (Grade A), moderate-quality (Grade B), and low-quality (Grade C) evidence. Results: For acute DVT or pulmonary embolism... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Journal Article
The American heart journal, ISSN 0002-8703, 2015, Volume 170, Issue 4, pp. 675 - 682.e8
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 12, pp. 1536 - 1544
Abstract Background The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown... 
Cardiovascular | Internal Medicine | chronic thromboembolic pulmonary hypertension | thrombolysis | long-term survival | pulmonary embolism | prognosis | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | CARDIOLOGY ESC | EUROPEAN-SOCIETY | TIME TRENDS | TRIAL | TASK-FORCE | HYPERTENSION | Pulmonary Embolism - prevention & control | Echocardiography | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Pulmonary Embolism - mortality | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Tenecteplase | Pulmonary Embolism - diagnostic imaging | Pulmonary embolism | Stroke (Disease) | Medicine, Experimental | Medical research | Cardiology | Cardiovascular agents | Heart | Therapy | Chest | Incidence | Design | Computed tomography | Motivation | Tomography | Diagnosis | Thromboembolism | Anticoagulants | Pulmonary arteries | Mortality | Statistical tests | Patients | Fibrinolysis | Survival | Computation | Diagnostic software | Death | Health risk assessment | Risk management | Angiography | Arches | Embolisms | Clinical trials | Population studies | Hemorrhage | Bleeding | Guidelines | Reperfusion | Risk assessment | Calcium-binding protein | Trends | Heart diseases | Injuries | Hypertension | Collapse | Stroke | Statistical analysis | Receiving | Complications | Risk reduction | Statistics | Pulmonary hypertension | Embolism | Computer programs | Contact | Thromboplastin | Medical prognosis | Fatalities | Ventricle | Heparin | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article